# ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)

> clinical trial · VERIFIED · 2026-08-03

Status: NOT_YET_RECRUITING · Sponsor: Xiamen Amoytop Biotech Co., Ltd. · Condition: Chronic Hepaititis B

- Company: Xiamen Amoytop Biotech Co., Ltd.
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07741461

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.